Pascal Soriot: Latest News

All news where Pascal Soriot is mentioned

30.04.2021 / 14:34

AstraZeneca reports $275M in sales from vaccine during 1st quarter

AstraZeneca said its COVID-19 vaccine sales were $275 million in the first-quarter and it is on track to deliver 200 million doses a month from April, as better-than-expected results and a second-half growth forecast boosted its shares.Chief Executive Pascal Soriot again defended the vaccine rollout on Friday, saying that Anglo-Swedish drugmaker had not overpromised on its ability to supply shots, as he defended big cuts in deliveries that prompted a European Union lawsuit.AstraZeneca, which has said it will not make a profit from the shot during the pandemic, was reporting financial details of distribution and sales of the vaccine it developed with Oxford University for the first time.It said the revenue included delivery of about 68

Pascal Soriot Eu Sweden covid-19 Coronavirus

AstraZeneca, EU to meet as vaccine row rumbles on

Pharmaceutical giant AstraZeneca will hold its third meeting with the European Commission and EU member states today as the fallout over the shortfall of vaccine supplies continues.

Pascal Soriot Italy Germany Britain Eu World Coronavirus

EU pressures AstraZeneca to deliver vaccines as promised

BRUSSELS – The European Union is pressuring the pharmaceutical company AstraZeneca to deliver more coronavirus vaccine doses to its 27 nations and to stick to its initial promises once the jab gets EU approval, especially since the bloc has already invested in enhancing production capacity.

Ursula Von Pascal Soriot Britain Israel Eu city Brussels Sweden president vaccine Coronavirus

AstraZeneca warned it must meet EU vaccine supply

European Commission President Ursula von der Leyen has warned the pharmaceutical company AstraZeneca that it must meet its contractual obligations in delivery supplies of the Covid-19 vaccine.

Ursula Von Pascal Soriot Eric Mamer Eu World Europe Coronavirus

UK approves use of 2nd COVID-19 vaccine with easier storage

LONDON – Britain on Wednesday authorized emergency use of a second COVID-19 vaccine, becoming the first country to greenlight an easy-to-handle shot that its developers hope will become the “vaccine for the world.”The Department of Health said it had accepted a recommendation from the Medicines and Healthcare Products Regulatory Agency to authorize the vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca.Britain has bought 100 million doses of the vaccine, and plans to begin injections within days. Hundreds of thousands of people in the U.K.

Pascal Soriot Germany Britain covid-19 vaccine

AstraZeneca: Shot will be effective against COVID-19 variant

LONDON – The head of drugmaker AstraZeneca, which is developing a coronavirus vaccine widely expected to be approved by U.K. authorities this week, said Sunday that researchers believe the shot will be effective against a new variant of the virus driving a rapid surge in infections in Britain.AstraZeneca chief executive Pascal Soriot also told the Sunday Times that researchers developing its vaccine have figured out a “winning formula” making the jab as effective as rival candidates.

Pascal Soriot Britain virus vaccine Coronavirus

AstraZeneca Covid vaccine has 'winning formula': CEO

The Covid-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a "winning formula" for efficacy, the company's chief executive said.

Pascal Soriot Britain city Oxford World Coronavirus

AstraZeneca Covid vaccine has 'winning formula' for efficacy: CEO Soriot

Covid-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a "winning formula" for efficacy, the company's chief executive said on Sunday.The vaccine, which is currently being evaluated by Britain's independent medicines regulator, provides "100% protection" against severe Covid disease requiring hospitalisation, Pascal Soriot said in an interview.He added he believes trials will show his firm has achieved a vaccine efficacy equal to Pfizer-BioNTech at 95% and Moderna at 94.5%."We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else," the chief executive said explaining data would be published at "some point".The UK

Pascal Soriot Britain city Oxford vaccine Government medicines

New AstraZeneca vaccine trial likely after lower dose performs better

AstraZeneca is likely to run an additional global trial to assess the efficacy of its Covid-19 vaccine, its chief executive Pascal Soriot was quoted as saying after questions over the results from its late-stage study.

Pascal Soriot Usa vaccine World Coronavirus

Astra-Oxford covid vaccine: Doses could be in short supply

AstraZeneca Plc and the University of Oxford followed Moderna Inc. and Pfizer Inc.

Pascal Soriot Britain city Oxford experts pandemic vaccine Government

Today marks an important milestone: AstraZeneca CEO on Oxford covid vaccine

Covid-19 has shown "an average efficacy of 70 percent" in trials.Commenting on the findings, Pascal Soriot, Chief Executive Officer, said: “Today marks an important milestone in our fight against the pandemic.

Andrew Pollard Pascal Soriot covid-19 pandemic vaccine

Oxford-AstraZeneca Covid-19 vaccine can be 90% effective, results show

covid vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen. The British-Swedish drugmaker's preliminary trial results mark a fresh breakthrough in the fight against a pandemic that has killed nearly 1.4 million people and roiled the global economy.

Pascal Soriot Sweden city Oxford covid-19 pandemic vaccine Coronavirus

Covid vaccine race won’t decide AstraZeneca's future

AstraZeneca Plc boss Pascal Soriot recently said he hoped there’d be more than one successful vaccine against Covid-19 given the sheer quantities required. His company’s shares have soared this year largely on hopes for the University of Oxford shot that it’s helping test, manufacture and eventually distribute. But on Monday AstraZeneca’s investors didn’t celebrate encouraging data from rival Pfizer Inc.’s coronavirus vaccine.

Pascal Soriot Britain city Oxford covid-19 testing pandemic vaccine Coronavirus

AstraZeneca plans to deliver vaccine trial data by year's end

This picture taken on May 23, 2020 shows a laboratory technician holding a dose of a COVID-19 novel coronavirus vaccine candidate. MLADEN ANTONOV/AFP via Getty Images LONDON - AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., Britain and other countries to determine its safety and effectiveness.

Pascal Soriot Britain Sweden city Oxford covid-19 2020 pandemic vaccine Coronavirus

Drug companies work jointly to boost coronavirus vaccine confidence

LONDON – Two firms developing COVID-19 vaccines say pharmaceutical companies are trying to give the public as much information as possible about their testing regimes as drugmakers and public health officials seek to boost confidence that any approved vaccine will be safe.AstraZeneca CEO Pascal Soriot and Paul Stoffels, chief scientific officer of Johnson & Johnson, said Thursday that they recognize the coronavirus emergency demands increased transparency from vaccine developers to ensure the public has faith in the end product.

Paul Stoffels Pascal Soriot information vaccine Coronavirus

Covid-19 vaccine 'won't be ready for second wave' says Oxford professor as trial restarts

Covid-19 vaccine at Oxford University started suffering from a neurological disease that prompted developers AstraZeneca to order a “global shutdown” of all tests. The company’s chief executive, Pascal Soriot, reportedly told investors that the woman who had volunteered to take part in the trials was showing signs of an as yet undiagnosed neurological problem.In the same call, reports medical news site Statnews, Soriot revealed that the trial also had to be suspended July after one test subject started experiencing neurological problems.

Pascal Soriot covid-19 testing vaccine

Oxford coronavirus vaccine trial 'to resume in days' after pause over volunteer illness

The trial of an Oxford coronavirus vaccine tipped to be the frontrunner in the fight against the pandemic could resume within days after it was halted.

Pascal Soriot Britain city Oxford vaccine Volunteers Coronavirus

pharmaceutical-technology.com

15.06.2020 / 10:05

58%

671

AstraZeneca agrees to supply 400 million Covid-19 vaccine doses to EU

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.AstraZeneca has signed an agreement with Europe’s Inclusive Vaccines Alliance (IVA) to supply up to 400 million doses of the Covid-19 vaccine, developed by the University of Oxford, by the end of this year. IVA, led by Germany, France, Italy and the Netherlands, expects the deal to boost the vaccine’s supply, making it available to other participating European countries.

Pascal Soriot Italy Germany Britain France Eu Netherlands city Oxford covid-19 information vaccine

pharmaceutical-technology.com

05.06.2020 / 13:53

60%

900

AstraZeneca signs $750m Covid-19 vaccine manufacturing deal

UK and US. It is working towards a supply chain to ensure global access and has received manufacturing capacity for two billion of the vaccine’s doses to date.

Pascal Soriot Usa Britain covid-19 vaccine Volunteers

Covid-19 vaccine makers may eventually have to infect subjects to get results

Drugmakers sprinting to deliver potential Covid-19 vaccines say they’re facing a new hurdle: declining infection rates that could make it hard to test their shots.

Pascal Soriot virus covid-19 vaccine infection

Global firms pledge to not profit from covid-19 vaccines till pandemic ends

J&J open to partner with Indian manufacturers to scale up capacity

Pascal Soriot city New Delhi India covid-19 testing pandemic vaccine

manchestereveningnews.co.uk

24.05.2020 / 13:59

69%

210

Brits will be able to get a coronavirus vaccine from September - if it works

British people will be able to access a coronavirus vaccine from September, the chief executive of drug maker AstraZeneca has said.

Andrew Marr Show Pascal Soriot Britain testing vaccine Government Coronavirus

AstraZeneca secures orders for virus vaccine under testing

LONDON – Drug maker AstraZeneca said Thursday it had secured its first agreements for 400 million doses of a COVID-19 vaccine it is testing, bolstered by an investment from the U.S. vaccine agency.

Pascal Soriot India Britain Sweden covid-19 testing vaccine Volunteers

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0